Evidence map›Paper›PMID 40791089›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Altered network efficiency in isolated REM sleep behavior disorder: A multicentric study.

Christina Tremblay, Alexandre Pastor-Bernier, François Rheault, Véronique Daneault, Violette Ayral, Marie Filiatrault, Liane Desaulniers, Andrew Vo, Jean-François Gagnon, Ronald B Postuma and 12 more

Abstract readMulticenter Study
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Altered network efficiency in isolated REM sleep behavior disorder: A multicentric study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Christina TremblayCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.ORCID 0000-0002-7747-8147
Alexandre Pastor-BernierCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
François RheaultSherbrooke Connectivity Imaging Lab, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Véronique DaneaultCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
Violette AyralCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
Marie FiliatraultCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
Liane DesaulniersCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
Andrew VoThe Neuro (Montreal Neurological Institute), McGill University, Montreal, Québec, Canada.
Jean-François GagnonCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
Ronald B PostumaCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.
Petr DusekDepartment of Neurology and Centre of Clinical Neurosciences, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.
Stanislav MarecekDepartment of Neurology and Centre of Clinical Neurosciences, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.
Zsoka VargaDepartment of Neurology and Centre of Clinical Neurosciences, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia.
Johannes C KleinOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Michele T HuOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Stéphane LehéricyInstitut du Cerveau (Paris Brain Institute, ICM), Sorbonne Université, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.
Isabelle ArnulfInstitut du Cerveau (Paris Brain Institute, ICM), Sorbonne Université, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.
Pauline DodetInstitut du Cerveau (Paris Brain Institute, ICM), Sorbonne Université, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.
Marie VidailhetInstitut du Cerveau (Paris Brain Institute, ICM), Sorbonne Université, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.
Jean-Christophe CorvolInstitut du Cerveau (Paris Brain Institute, ICM), Sorbonne Université, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Paris, France.
ICEBERG Study Group
Shady RahayelCentre for Advanced Research in Sleep Medicine, Hôpital du Sacré-Cœur de Montréal, Montreal, Québec, Canada.

Funding

4D Pharma, AbbVie Inc., AcureX Therapeutics, Allergan, Amathus Therapeutics, Aligning Science Across Parkinson's (ASAP), Avid Radiopharmaceuticals, Bial Biotech, Biogen, BioLegend, Bristol Myers Squibb, Calico Life Sciences LLC, Celgene Corporation, DaCapo Brainscience, Denali Therapeutics, The Edmond J. Safra Foundation, Eli Lilly and Company, GE Healthcare, GlaxoSmithKline, Golub Capital, Handl Therapeutics, Insitro, Janssen Pharmaceuticals, Lundbeck, Merck & Co., Inc., Meso Scale Diagnostics, LLC, Neurocrine Biosciences, Pfizer Inc., Piramal Imaging, Prevail Therapeutics, F. Hoffmann-La Roche LtdAgence Nationale de la Recherche ANR-11-INBS-0006Alzheimer Society Canada 0000000082Canada Research Chair in Cognitive Decline in Pathological AgingCanadian Institutes of Health Research (CIHR)CIHR, Michael J. Fox Foundation, NIH, Roche Diagnostics, and the Weston FoundationControl-PD (Joint Programme-Neurodegenerative Disease Research [JPND] Cognitive Propagation in Prodromal Parkinson's disease)Control-PD (JPND Cognitive Propagation in Prodromal Parkinson's Disease)Czech Health Research Council NU21-04-00535Department of Health and Social CareÉlectricité de France (Fondation d'Entreprise EDF)European Union - Next Generation EUFinanced by European Union - Next Generation EUFondation Thérèse et René PlaniolFonds de recherche du Québec - Santé (FRQ-S)Fonds de recherche du Québec - Santé, the Canadian Institutes of Health Research, the W. Garfield Weston Foundation, the Michael J. Fox Foundation for Parkinson's Research, and the National Institutes of HealthFonds Saint-MichelGenentech Inc., Sanofi Genzyme, Servier, Takeda Pharmaceutical Company, Teva Neuroscience, Inc., UCB, Vanqua Bio, Verily Life Sciences, Voyager Therapeutics, Inc., and Yumanity Therapeutics, IncInstitut de France to Isabelle Arnulf (for the ALICE Study)Michael J. Fox FoundationNational Institute for Health and Care Research (NIHR) Oxford Health Clinical Research Facility and the NIHR Oxford Biomedical Research CentreNational Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)National Institute for Neurological Research LX22NPO5107NIHR Oxford Biomedical Research Centre (BRC)NIHR Oxford Health Clinical Research FacilityParis Institute of Neurosciences - IHU IAIHU-06Parkinson Canada 2023-0000000122Parkinson's disease from Energipole (M. Mallart)Parkinson Society Canada PPG-2023-0000000122Parkinson's UK J-2101Parkinson's UK, the Oxford Biomedical Research Centre, CPT, EPND, and the Michael J. Fox FoundationProgramme d'investissements d'avenir ANR-10-IAIHU-06Société Française de Médecine Esthétique (M. Legrand)the Paris Institute of Neurosciences IHU (IAIHU-06)W. Garfield Weston Foundation
6 · The paper itself

Abstract

introductionIsolated rapid eye movement (REM) sleep behavior disorder (iRBD), characterized by abnormal movements during REM sleep, is a prodromal stage of dementia with Lewy bodies (DLB) and Parkinson's disease (PD). While iRBD shows emerging brain changes, their impact on structural connectivity and network efficiency, and their predictive value, remain poorly characterized.

methodsIn this international prospective study, 198 polysomnography-confirmed iRBD patients and 174 controls underwent diffusion magnetic resonance imaging and were analyzed. Cutting-edge diffusion tractography and network-based statistics were applied to reconstruct individual connectomes and assess network properties predicting DLB or PD.

resultsStructural architecture was already disrupted in iRBD, with both reduced and compensatory increased connections. Global efficiency was decreased. Local efficiency in motor regions was altered and associated with early clinical symptoms. Altered local efficiency in the supramarginal gyrus predicted DLB only. DISCUSSION: Early disruption of brain architecture in iRBD predicts progression to synucleinopathy-related dementia, offering a novel potential prognostic biomarker. HIGHLIGHTS: Isolated rapid eye movement sleep behavior disorder (iRBD) patients show significant alterations in inter-regional structural connectivity. Global efficiency is reduced in iRBD compared to controls. Areas with increased local efficiency contribute to decreased global efficiency. Altered network efficiency is associated with emerging Parkinsonian features. Higher supramarginal efficiency predicts dementia with Lewy bodies in iRBD.

Indexed as

BrainLewy Body DiseaseNerve NetREM Sleep Behavior DisorderAgedConnectomeDiffusion Magnetic Resonance ImagingDiffusion Tensor ImagingFemaleHumansMaleMiddle AgedParkinson DiseasePolysomnographyProspective Studiesdementia with Lewy bodiesdiffusion magnetic resonance imaginggraph theoryparasomniassleepstructural connectivitysynucleinopathies

Identifiers

PMID40791089
PMCPMC12340432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.